TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Talis Biomedical Corporation - common stock (TLIS)
Company Research
Source: GlobeNewswire
NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Talis Biomedical Corporation (NASDAQ: TLIS) on behalf of long-term stockholders following a class action complaint that was filed against Talis on March 8, 2022 with a Class Period relating to stock purchases made pursuant to the Company’s February 2021 IPO. Our investigation concerns whether the board of directors of Talis have breached their fiduciary duties to the company. The complaint filed alleges that the Registration Statement was false and misleading and omitted to state material adverse facts. Specifically, Defendants failed to disclose to investors: (1) that the comparator assay in the primary study lacked sufficient sensitivity to support Talis’s EUA application for Talis One COVID-19 test; (2) that, as a result, Talis was reasonably likely to experience delays in obtaining regulatory approval for the Tal
Show less
Read more
Impact Snapshot
Event Time:
TLIS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLIS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLIS alerts
High impacting Talis Biomedical Corporation - common stock news events
Weekly update
A roundup of the hottest topics
TLIS
News
- Bragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and RTR on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- Respiratory Infection Diagnostic Technology Market Analysis Report 2024: Multiplex Advancements and Geographic Expansion 2023-2027 - Diagnostic Sector Witnesses Surge [Yahoo! Finance]Yahoo! Finance
TLIS
Sec Filings
- 4/11/24 - Form 8-K
- 4/1/24 - Form EFFECT
- 3/28/24 - Form 10-K
- TLIS's page on the SEC website